| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $332.9M | +7.6% |
| Cost of Revenue | $77.6M | +4.6% |
| Gross Profit | $255.3M | +8.6% |
| R&D Expense | $80.9M | -3.1% |
| SG&A Expense | $61.8M | +5.0% |
| Operating Income | -$41.7M | +42.5% |
| Interest Expense | $6.1M | +109.8% |
| Pre-tax Income | -$26.0M | +59.8% |
| Income Tax | $1.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.9M | +23.9% |
| Short-term Investments | $89.3M | -55.0% |
| Accounts Receivable | $48.1M | +27.6% |
| Current Assets | $251.2M | -26.5% |
| Total Assets | $340.3M | -23.4% |
| Current Liabilities | $88.0M | +24.4% |
| Long-term Debt | $216.5M | -36.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.3M | +208.3% |
| Investing Cash Flow | $105.3M | +3639.1% |
| Financing Cash Flow | -$114.0M | -9281.6% |
| — |
| Net Income | -$27.0M | +58.2% |
| EPS (Basic) | -$0.35 | +59.3% |
| EPS (Diluted) | -$0.35 | +59.3% |
| Total Liabilities |
| $306.9M |
| -26.7% |
| Stockholders' Equity | $33.4M | +30.7% |